Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in generalized social anxiety disorder
NCT00612859Phase 2Completed
- Sponsor
- UCB
- Start
- Sep 2003
- Primary completion
- Jun 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of levetiracetam in Social Anxiety Disorder (SAD), sponsored by UCB. Started Sep 2003; status: completed.
02
Drugs
levetiracetam
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00612859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612859.